The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...

An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical studies, the agency said on Monday. To remedy this shortfall, the U.S.

In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to show the effectiveness of a new drug. The guidance, ...

On April 29, 2026, the House Appropriations Committee advanced the Fiscal Year 2027 Agriculture, Rural Development, Food and Drug Administration, ...

Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically ...

Key market opportunities in decentralized clinical trials include increased adoption of hybrid trial designs, AI-driven optimization, and virtual trial platforms driven by telemedicine and digital ...

Prime Medicine reports positive initial Phase 1/2 trial results for PM359, showing safety and efficacy in treating Chronic Granulomatous Disease. Prime Medicine, Inc. has announced positive initial ...

CRISPR Therapeutics reports promising Phase 1 clinical data for CTX310™, with significant triglyceride and LDL reductions, and updates on other programs. CRISPR Therapeutics announced promising new ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...